Thermo Scientific portable solutions deliver specialized identification and analysis of raw materials for the highly regulated global pharmaceutical industry.
Thermo Scientific portable solutions deliver specialized identification and analysis of raw materials for the highly regulated global pharmaceutical industry.
With greater than 650 GMP facility installations worldwide, we’ve successfully implemented our solutions into the top pharmaceutical companies and regulatory enforcement agencies worldwide – enabling them to increase productivity and realize a rapid return on their investment.
We are more than the leading provider of portable analytical instruments. We are a true partner, delivering expertise and solutions to improve processes, reduce risk & costs, and achieve competitive advantage.
Developed with in-depth pharmaceutical industry experience, Thermo Scientific handheld analyzers provide manufacturers with a portable solution to achieve quality initiatives throughout the manufacturing process.
The Thermo Scientific TruScan RM, based on Raman spectroscopy, and the Thermo Scientific microPHAZIR RX, based on Near-Infrared spectroscopy, are simple to use and enable on-the-spot, actionable Pass-Fail results within seconds.
Both analyzers are 21 CFR part 11 compliant and meet the requirements of global pharmacopeias. Our handheld solutions are used by 24 of the top 25 global pharmaceutical manufacturers, driving significant time and cost savings.
Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.
Thermo Scientific – Portable Analytical Instruments
Website: www.thermoscientific.com/quality
E-mail: sales.chemid@thermofisher.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.